Ruchała, Marek

Chromogranin A—unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls

Gut, P., Czarnywojtek, A., Fischbach, J., Bączyk, M., Ziemnicka, K., Wrotkowska, E., Gryczyńska, M., & Ruchała, M. (2016) · Archives of Medical Science

Neuroendocrine Tumor Research AdvancesNeuropeptides and Animal Physiology

Cited by 144

Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People

Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health

Exercise and Physiological ResponsesAdipokines, Inflammation, and Metabolic Diseases

Cited by 79

Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of Polish physicians. *THESIS: Treatment of hypothyroidism in Europe by specialists: an international survey

Bednarczuk, T., Attanasio, R., Hegedüs, L., Nagy, E. V., Negro, R., Papini, E., Perros, P., & Ruchała, M. (2021) · Endokrynologia Polska

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 33

Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome

Kałużna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmańska, K., Janicki, A., Samarzewska, K., Ruchała, M., & Ziemnicka, K. (2022) · Therapeutic Advances in Endocrinology and Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 32

Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation — Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]

Gietka-Czernel, M., Hubalewska-Dydejczyk, A., Kos-Kudła, B., Lewiński, A., Ruchała, M., Syrenicz, A., & Zgliczyński, W. (2020) · Endokrynologia Polska

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 13